In vivo [1, 2] and in vitro [3, 4] studies have demonstrated that inhalation anaesthetics produce direct negative chronotropic and inotropic effects. However, the specific sites and mechanisms of their action are not well established. Potential mechanisms of action for inhalation anaesthetics in cardiac cell have been proposed: slowing of calcium flux through voltage-gated calcium channels [5] ; a change in calcium flux between myoplasm and sarcoplasmic reticulum or other intracellular pools [6] and interaction between the anaesthetic drug and protein molecules [7, 8] . In addition, it has been suggested [9] that halothane interacts with a specific type of membrane protein, the^guaninejiucleotide-binding proteins (G proteins). It is becoming increasingly evident that opioid receptors are functionally linked to G proteins [10] . Moreover, there is evidence for the presence of different subtypes of opioid receptor (mu, delta and kappa) in heart muscle-both in the atria and in the ventricles [11, 12] .
The aim of the present study was to investigate the interaction between halothane and specific opioid agonists on spontaneous atrial rate by using selective agonists: morphine (preferential mu agonist), [D-ala* N-mephe 4 , gly-ol 6 ]-enkephalin (DAGO-specific mu agonist), [D-pen 25 ]-enkephalin (DPDPEspecific delta agonist) and trans-3,4-dichloro-Nmethyl-N-[2-(l-pyrrolikynyl)cyclohexyl]-bencetamide methane sulphonate (U-50,488H-specific kappa agonist) and naloxone-a non-specific antagonist.
MATERIALS AND METHODS
Isolated right atria were taken from Sprague-Dawley rats (« = 88) of both sexes (weight 150-200 g) killed by a blow on the head and immediate decapitation. The chest was opened with a midsternal incision and the right atrium isolated by a technique similar to that described previously [13] . The right atrium and sino-atrial node were suspended in a 10-ml organ bath. Tyrode solution of the following composition (nmol litre" 1 ) was used: NaCl 136.9; KC15.0; MgCl 2 1.05; NaH 2 PO 4 0.4; NaHCO 3 11.9; CaCl 2 1.8; glucose 5.0. The bathing solution was maintained at 37 °C and pH 7.4 and bubbled with 5% carbon dioxide in oxygen. When halothane was used, the carbon dioxide-oxygen mixture was passed through a Fluotec Mark II vaporizer and the delivered concentration of halothane verified by gas chromatography. The right atrium was beating spontaneously and was suspended under a resting tension of 0.5 g and equilibrated for 30 min before the start of the experiments. The frequency of spontaneous contractions was measured using a force-displacement transducer (Grass FT-03) and recorded on a Dynograph Beckman polygraph. Halothane was delivered to the organ bath in a concentration of 1.5 %. When halothane became effective, the preparation was equilibrated for an additional 15 min in the presence of the anaesthetic. The halothane concentration remained unchanged throughout each experiment.
Increasing concentrations of morphine, DAGO, DPDPE or U-50,488H were added cumulatively to ) were added directly to the bath during the initial equilibration period and were present throughout the experiment. Control concentration-response curves were obtained for 0.1%, 0.3%, 0.5%, 1%, 1.5%, 2% and 2.5% halothane and naloxone (data not shown). Each drug concentration was added to the organ bath at 3-min intervals. Control experiments without drugs showed that the frequency of contractions did not change.
The drugs used in this study were halothane
-bencetamide methane sulfonate (a gift from Upjohn)) and naloxone hydrochloride (a gift from Merck, Sharp & Dohme). All drugs were dissolved in distilled water.
The effects of halothane or opioid agonists alone are expressed as percent changes from the baseline values. Similarly, the effects of U-50,488H in the presence ofhalothane or in the presence ofhalothane plus naloxone are expressed as percent changes from the baseline values after halothane or halothane with naloxone. To compare the inhibitory effects of U-50,488H in the absence or in the presence of halothane or halothane with naloxone, we measured the 50% inhibitory concentration (CI 60 ) for each set of experiments.
Data were examined by analysis of variance with Student's t test for individual comparison. The IC 50 was calculated by linear regression of the logconcentration plot of the data with the aid of a computer program [14] . P < 0.05 was considered significant.
RESULTS
Halothane 0.3-1.5% did not change auricular automaticity compared with the control (table I) . However, it produced a small (6 (1.6)%, maximum) but significant (P < 0.05) effect at the greatest concentration tested (2.5%).
The data obtained for morphine, DAGO and DPDPE with or without 1.5 % halothane are shown in table II. This concentration of halothane alone produced a small (3%) but not significant decrease in auricular chronotropism (table I) . Morphine alone did not alter atrial chronotropism at concentrations of 1 x 10~n to 1 x 10" 6 mol litre" 1 . However, morphine 5 x 10" 4 mol litre" 1 produced a small (12(2.7)% maximum) but significant (P < 0.05) decrease. When 1.5% halothane was present in the organ bath, morphine 5 x 10" 4 mol litre" 1 increased auricular automaticity (table II) . Halothane did not modify the chronotropic effects induced by DAGO or DPDPE. All tested concentrations of DAGO induced a significant decrease (P < 0.05) in auricular chronotropism. The maximal effect (8 (0.6)%) was obtained with 5 x 10" 4 mol litre" 1 . Similar results were obtained when 1.5 % halothane was present in the organ bath. In this case the maximal effect was 10(1)%-similar to that found with DAGO alone (table II) . DPDPE 1 x 10" 7 to 5 x 10" 4 mol litre" 1 induced a significant (P < 0.05) decrease in auricular chronotropism compared with control. The maximal effect was 11 (1.8)%, similar to that described with DAGO or morphine. Halothane 1.5% did not modify the auricular chronotropism induced by DPDPE. When halothane was present in the organ bath, the maximal effect obtained with DPDPE was 5 (1.2)% (table II) . Concentration-response curves for U-50,488H obtained in the absence and in the presence of halothane or halothane with naloxone are illustrated in figure 1 . U-50,488H alone significantly decreased the frequency of contraction at concentrations from lxlO" 8 to 5 x 10" 4 mol litre"
1
. U-50,488H 5 x 10" 4 mol litre" 1 induced a significant (P < 0.01) negative chronotropic effect compared with the control. The maximal effect was (75 (3.3)%). Halothane 1.5% modified the maximal negative chronotropic response to U-50,488H. In the presence of halothane, U-50,488H 1 x 10" 6 mol litre" 1 was capable of producing a 100% inhibition of auricular frequency. At this concentration, U-50,488H alone produced a reduction in auricular chronotropism (14(1.8)%) significantly (P < 0.001) less than that obtained with U-50,488H in the presence of halothane (100 (0)%).
We obtained concentration-response curves for U-50,488H in the presence of halothane and naloxone to determine whether naloxone antagonizes the effects of U-50,488H on auricular chronotropism in the presence of halothane ( fig. 1) . The concentrations of naloxone (5 x 10" 7 or 1 x 10"* mol litre" 1 ) used in these experiments were devoid of effect on auricular frequency. The maximal effect obtained with U-50,488H 1 x 10" 6 mol litre" 1 in the presence ofhalothane was 100 (0)%. Naloxone progressively reduced this effect (57 (2.3)% and 21 (1.2)% in the presence of naloxone 5 x 10" 7 and 1 x 10"* mol litre" 1 , respectively).
The concentrations of U-50,488H that caused a 50% of inhibition in the auricular chronotropism (IC 60 ) in the absence or presence of halothane or halothane with naloxone are given in table III.
Halothane increased the potency of U-50,488H significantly.
DISCUSSION
In order to avoid extrinsic mechanical, nervous and humoral factors that are difficult to control in in vivo experiments, we have used the isolated right atrial preparation to study the effects of morphine (preferential mu agonist), DAGO (specific mu agonist), DPDPE (specific delta agonist) and U-50,488H (specific kappa agonist) and the interaction between halothane and specific opioid agonists. This method has been used widely to evaluate the actions and interactions between different drugs on chronotropic automaticity [13, 15] . Morphine, DAGO, DPDPE and U-50,488H caused a direct negative chronotropic effect on the isolated right atrium, in agreement with the results of other studies [16] [17] [18] [19] . The inhibitory effect of U-50,488H was consistently greater than diat of morphine, DAGO or DPDPE, suggesting that the kappa opioid receptors are those principally implicated in the negative chronotropic effects induced by opioid agonists.
Our results also showed that halothane had a direct negative chronotropic action, in agreement with other in vitro studies [20, 21] . Although the precise mechanisms by which halothane produce a negative chronotropic effect in normal cardiac muscle are not well established, several different mechanisms of action have been proposed: impairment of excitation-contraction coupling in the myocardium by reduction of the influx of extracellular Ca 2+ and the amount of Ca 2+ in the intracellular stores, leading to a decrease in calcium ions available for activation of myocardial contraction [22, 23] ; reduction of ATPase activity in the myofibrils [7] ; interaction with G proteins [9] . It is known that opioid receptors are functionally linked to G proteins [10] and it is possible that die chronotropic effects of halothane are mediated by these receptors. A previous report from our laboratory demonstrated that naloxone antagonized the cardiac effects of halothane [24] .
The major aim in our study was to investigate the combined direct effects of halothane with morphine, DAGO, DPDPE or U-50,488H on spontaneous sino-atrial rate. Using isolated right atria, in which opioid receptors are present [11, 12] , we have demonstrated that U-50,488H has a potentiating effect in the presence of halothane. However, halothane did not modify the potency of morphine, DAGO or DPDPE. Our results indicate that halodiane and U-50,488H could interact in a synergistic manner. These results are consistent with those of other investigators [25] who reported an interaction between halothane and opioids in vivo.
An interaction between halothane and morphine has been demonstrated in longitudinal muscle preparations of guineapig myenteric plexus [26] and in isolated left atria [27] . However, in the present study halothane did not change the effects of morphine, DAGO or DPDPE. The difference observed between these experiments and the present results could be attributable to the nature of the preparation used in this study. The sympathetic axons innervating the sinus node of the rabbit possess presynaptic opioid kappa, but not mu or delta, receptors [28] . Similar results were obtained in guineapig atrial noradrenergic nerves [29] .
Diltiazem, a calcium channel antagonist, usually augments, but in the presence of an increased calcium concentration inhibited, the cardiac effect induced by halothane [20] . Opioid binding to specific receptors on the cellular membrane triggers a variety of changes, through G proteins, such as inhibition of ionic conductance [30, 31] . It has been established that mu, delta and kappa receptors are coupled differentially to ionic conductances [31] . Thus mu and delta receptors have been shown to be coupled to K + conductance, while the kappa receptors cause a reduction in voltage-dependent Ca 2+ conductance [32, 33] . These observations support our hypothesis that halothane and U-50,488H could interact in a synergistic manner. Furthermore, naloxone antagonized the interaction between halothane and U-50,488H in a dose-related manner in our preparation, indicating that the interaction between halothane and U-50,488H could be related to events occurring at the opioid receptor complex.
